Deuterated Products
Product Description
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
More Products from CLEARSYNTH LABS LIMITED (99)
-
Product Tamoxifen
Tamoxifen is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4. In breast cancer, the gene repressor ... -
Product 2,2-Dipyridylamine
A metal-complexing agent; an effective iron chelating agent to help protect against UVB radiation. An impurity of Chlorpheniramine Maleate . ;Impurity in commercial preparations of Chlorpheniramine. -
Product Acetone-d6
Acetone-d₆ is a versatile deuterated reagent and solvent designed for stable isotope labeling applications. It is extensively used in the synthesis of deuterated APIs, intermediates, metabolites, and analytical reference standards. Its high isotopic purity ensures reliable deuterium incorporation, making i... -
Product Bromocyclopentane-d9
Bromocyclopentane-d₉ is a high-purity deuterated alkyl bromide widely used as a versatile building block in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient introduction of a deuterated cyclopentyl group into complex organi... -
Product Methyl boronic-d3
Methylboronic Acid-d₃ (CD₃B(OH)₂) is a high-purity deuterated organoboron building block widely used in the synthesis of stable isotope-labeled pharmaceuticals, advanced intermediates, and analytical reference standards. It is an essential reagent for Suzuki–Miyaura cross-coupling reactions, enabling the e... -
Product Nitrosamine and Drug Impurities | Testing and Analytical Services
Clearsynth is a globally trusted partner for reference standards and research chemicals. We offer over 3,000 nitrosamine impurities, 5,000+ stable isotopes, and 10,000+ drug impurities, encompassing a vast portfolio of more than 325,000 products serving various industries, including pharmaceuticals, clinic... -
Product Reference Standards and NMR Solvents
Clearsynth provides a wide range of high-purity NMR solvents designed to ensure optimal resolution and reliable analysis, supporting both research and quality control applications
Benzene D6 , Chloroform-D , Dimethyl Sulphoxide D6 (DMSO D6) , Methanol D4 , Deuterium Oxide , Tetrahydrofuran... -
Product 2-Amino-1-(4-methylphenyl)ethanol-d3
A α-substituted phenylethanolamines that binds reversibly to the octopaminergic receptor. -
Product N-Acetyl Metoclopramide-d3
Labelled N-Acetyl Metoclopramide. N-Acetyl Metoclopramide is a related compound of Metoclopramide. -
Product 2-Amino-5-(methyl-d3)-pyridine
Molecular formula: C₆H₅D₃N₂Molecular weight: 111.16 -
Product rac-cis-Ambroxol-d5
Labelled anaologue of cis-Ambroxol, the cis-isomeric impurity of Ambroxol. cis-Ambroxol is a metabolite Bromhexine. -
Product 4-Acetamidobenzenesulfonic Acid-d4 Pyridine (Major)
Labelled 4-Acetamidobenzenesulfonic Acid. 4-Acetamidobenzenesulfonic Acid is a metabolite of Sulfanilic acid.
CLEARSYNTH LABS LIMITED resources (1)
-
Video Clearsynth Intro Video
Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.